Previous 10 | Next 10 |
MONTREAL, May 25, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has elucidated the mechanism of action of Adva-27...
MONTREAL, May 20, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has paid off $250,000 in variable rate convertibl...
Sunshine Biopharma (SBFM): Q1 Cash & equivalents of $1,796,596 as of March 31, 2021, the period end.Press Release For further details see: Sunshine Biopharma reports Q1 results
MONTREAL, May 13, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs, announced that it has filed its 2021 first quarter report. The Report sh...
MONTREAL, May 04, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has timely filed a nonprovisional patent applicat...
MONTREAL, April 22, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that RB Capital has injected an additional investment o...
MONTREAL, April 19, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has successfully completed a Maximum Tolerated ...
MONTREAL, March 23, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has received a total of $2,054,000 to date from...
Sunshine Biopharma (SBFM) announces that it has received a "Notice of Allowance" from the European Patent Office for a new patent application covering Adva-27a, the company’s flagship anticancer compound.This newly issued patent contains new subject matter and extends the propriet...
MONTREAL, March 11, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs today announced that it has received a “Notice of Allowanceȁ...
News, Short Squeeze, Breakout and More Instantly...
Sunshine Biopharma Inc. Company Name:
SBFM Stock Symbol:
OTCMKTS Market:
Sunshine Biopharma Inc. Website:
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 3.5% to $129.61 on volume of 255,610,868 shares Longeveron Inc. (LGVN) rose 48.6% to $2.69 on volume of 190,987,878 shares PROSHARES TRUST (SQQQ) fell 1.6% to $8.54 on volume of 116,711,722 shares Tesl...
A look at the top 10 most actives in the United States KWESST Micro Systems Inc. (KWE) rose 117.2% to $0.8686 on volume of 324,599,275 shares NVIDIA Corporation (NVDA) rose 0.7% to $121.79 on volume of 306,257,100 shares Nauticus Robotics Inc. (KITT) rose 49.0% to $0.2309 on volume of 208...